机器人辅助根治性膀胱切除联合体内回肠通道术中输尿管支架置入的围手术期并发症与省略支架的影响
本机构2017年11月至2023年6月行机器人辅助根治性膀胱切除联合体内回肠通道术的133例患者中,90例(68%)置入输尿管支架、43例(32%)未置入;置入组30天尿路感染率显著更高(差异19%,95%CI 9.0%-29%,P=0.007),输尿管肠吻合口并发症复合终点两组无统计学显著差异(20% vs 9.5%,P=0.2);作者认为省略支架安全可行,但需随机试验验证。
要点
- 置入支架组30天尿路感染率显著高于未置入组(差异19%,95%CI 9.0%-29%,P=0.007)。
- 输尿管肠吻合口并发症复合终点置入组20% vs 未置入组9.5%,差异无统计学显著(P=0.2)。
- 作者认为RARC-IC术中省略输尿管支架安全可行,但需随机试验确定支架对术后并发症风险的影响。
核心结论
- 作者认为在机器人辅助根治性膀胱切除联合体内回肠通道术中省略输尿管支架置入是安全可行的。
- 作者提出需开展随机试验以确定支架对RARC-IC术后并发症风险的影响。
研究设计与样本
- 本研究为单中心病例系列,回顾了2017年11月至2023年6月在本机构实施的全部机器人辅助根治性膀胱切除联合体内回肠通道术。
- 自2021年8月起常规省略输尿管支架;共纳入133例患者,其中90例(68%)置入输尿管支架、43例(32%)未置入。
- 主要结局为RARC-IC术后30天和90天内输尿管肠吻合口并发症(尿漏、尿路感染、脓肿和/或脓毒症);次要结局包括伤口感染、急诊就诊、住院再入院和输尿管狭窄的发生率。
主要发现
- 输尿管肠吻合口并发症复合终点置入支架组为20%、未置入支架组为9.5%,差异10%(95%CI -3.4%至24%,P=0.2),未达统计学显著。
- 置入支架组30天尿路感染率显著高于未置入组,差异19%(95%CI 9.0%-29%,P=0.007)。
- 置入支架组30天再入院率高于未置入组(19% vs 9.8%),差异9.1%(95%CI -4.8%至23%,P=0.3),未达统计学显著。
临床怎么用
- 作者认为RARC-IC术中省略输尿管支架置入安全可行。
- 作者提出需随机试验确定支架对RARC-IC术后并发症风险的影响。
局限性
- 缺乏随机化。
- 无法评估部分结局,包括输尿管梗阻或狭窄。
- 作者提出需开展随机试验以确定支架对术后并发症风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ureteral stents are commonly placed intraoperatively during radical cystectomy, although their efficacy in reducing complications is unproven. We compared clinical outcomes among patients undergoing robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC) with or without ureteral stents to determine if omission of ureteral stents affects postoperative complications. MATERIALS AND METHODS: All RARC-IC surgeries performed at our institution between November 2017 and June 2023 were reviewed. Beginning August 2021, ureteral stents were routinely omitted. Primary outcome was ureteroenteric anastomosis complications (urine leak, UTI, abscess, and/or sepsis) within 30 and 90 days of RARC-IC. Secondary outcomes included rates of wound infections, urgent care center visits, inpatient readmissions, and ureteral stricture. RESULTS: Among 133 patients included, 90 patients (68%) received a ureteral stent and 43 (32%) did not. Composite ureteroenteric anastomosis complications were higher in the stented group (20% vs 9.5%, 10% difference, 95% CI, -3.4% to 24%, P = .2), though not statistically significant. The stented group had a significantly higher 30-day UTI rate (19% difference, 95% CI, 9.0%-29%, P = .007). The 30-day readmission rates were higher in the stented group, although differences did not meet statistical significance (19% vs 9.8%, 9.1% difference, 95% CI, -4.8% to 23%, P = .3). Limitations include lack of randomization and inability to evaluate some outcomes, including ureteral obstruction or strictures. CONCLUSIONS: Omission of ureteral stent placement at RARC-IC is safe and feasible. Randomized trials are warranted to determine the effects of stents on risk of postoperative complications after RARC-IC.
引用
- Tallman JE, Vertosick EA, Alam SM, et al. Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit. J Urol. 2024. PMID: 39666958. doi:10.1097/JU.0000000000004387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。